Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.22M Sell
41,354
-1,228
-3% -$73.1K 0.01% 860
2025
Q4
$2.56M Sell
42,582
-1,352
-3% -$79.4K 0.01% 745
2025
Q3
$2.57M Buy
43,934
+3,746
+9% +$213K 0.02% 650
2025
Q2
$2.27M Buy
40,188
+5,838
+17% +$328K 0.02% 617
2025
Q1
$1.82M Buy
34,350
+4,421
+15% +$222K 0.02% 579
2024
Q4
$1.38M Buy
29,929
+7,471
+33% +$366K 0.02% 630
2024
Q3
$1.14M Buy
22,458
+2,051
+10% +$101K 0.02% 532
2024
Q2
$996K Buy
+20,407
New +$942K 0.04% 353

Other funds holding ROL

&Partners's ROL Position: Q1 2026 in Review

&Partners reduced its Rollins (ROL) stake by 2.9% in Q1 2026, selling an estimated $73.1K and leaving 41,354 shares worth $2.22M. The position accounts for 0.01% of the portfolio, ranked #860.

&Partners first reported a position in ROL in Q2 2024 and has held it in 8 quarters since. The position peaked at $2.57M in Q3 2025. 837 funds tracked by Wall St. Rank hold ROL as of Q1 2026.

  • &Partners held 41,354 shares of Rollins worth $2.22M as of Q1 2026.
  • &Partners sold 1,228 Rollins shares in Q1 2026, an estimated $73.1K.
  • Rollins made up 0.01% of &Partners's portfolio in Q1 2026, its #860 holding.
  • &Partners first reported a position in Rollins in Q2 2024 and has held it in 8 quarters since.
  • &Partners's Rollins position peaked at $2.57M in Q3 2025.
  • 837 funds tracked by Wall St. Rank held Rollins as of Q1 2026.

Based on &Partners's 13F filing for Q1 2026, filed 15 May 2026.